📰 Advanced Solid Tumours News
Advanced Solid Tumours News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Advanced Solid Tumours. Real-time updates on events, politics, business and more.
March 3, 2023
Imugene Ltd (ASX:IMU, OTC:IUGNF) welcomes the news that the first patients have been dosed in its Phase 1 MAST (metastatic advanced solid tumours) study...
January 9, 2023
Imugene Ltd (ASX:IMU, OTC:IUGNF) has received Human Research Ethics Committee (HREC) approval to kick off an Australian Phase 1 clinical trial of its...
January 9, 2023
Imugene has now crossed ethics approval off is list, and the way is now clear for clinical trials to begin in Australia.
May 18, 2022
Imugene Limited, a clinical stage immuno-oncology company, and City of Hope, one of the largest cancer research and treatment organizations in the United States, today announced that the first patient was dosed in a Phase 1 clinical trial evaluating the safety of novel cancer-killing virus CF33-hNIS VAXINIA when used in people with advanced solid tumors.